MedDataX Logo

A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma

NCT00785083 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2016-11-18

No results posted yet for this study

Summary

This study will evaluate the effect of FTY720 on the lung function of patients with moderate asthma

Conditions

  • Asthma

Interventions

DRUG

FTY720

DRUG

Placebo

Sponsors & Collaborators

  • Novartis

    lead INDUSTRY

Principal Investigators

  • Novartis · Novartis Investigator Site

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2009-02-28

Countries

  • United Kingdom

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00785083 on ClinicalTrials.gov